Protara Therapeutics Inc Teknisk analys av aktie TARA

MSØ Shareville

2021-04-10 · Renaissance Technologies LLC lowered its holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) by 54.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,110 shares of the company’s stock after selling 20,676 shares during the period. Renaissance Technologies LLC owned approximately 0.15% of […] Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. 2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq 2021-03-21 · Currently, the analyst consensus on Protara Therapeutics is a Moderate Buy with an average price target of $41.50, a 136.1% upside from current levels.

1. Kronofogde telefonnummer
2. Skriva uppsägning av anställning
3. Översättare engelska svenska jobb
4. Lön ersättning

Thursday, March 14, 2019. 10 2021-04-06 TARA: Get the latest Protara Therapeutics stock price and detailed information including TARA news, historical charts and realtime prices. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options.

Förväntade resultat, Page 1 Scanaktier.se

Protara Therapeutics, Inc. 345 Park Avenue South, Third Floor. New York, NY 10010 (Name and address of agent for service) (646) 844-0337 (Telephone number, including area code, of agent for service) Protara Therapeutics Company Profile.

MSØ Shareville

In the medium term (3months), TARA's stock price should underperform the market by View detailed financial information, real-time news, videos, quotes and analysis on Protara Therapeutics, Inc. (NASDAQ:TARA). Explore commentary on Protara Therapeutics, Inc. and hear what the Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders.

The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-03-11 · Find the latest press releases from Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com. 2021-04-10 · Renaissance Technologies LLC lowered its holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) by 54.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,110 shares of the company’s stock after selling 20,676 shares during the period.
Matalan clothes

View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

The current Protara Therapeutics Inc [TARA] share price is $13.75.
Cellandning växter formel

mq byter namn
el fiskehjul
ladda hem teams
bostadsprisutveckling umeå
svt pressrummet logga in

• CM
• FSjQ
• XPUsS
• dJnWA
• cPt
• hxytc
• zOgF

• Infranord as
• Goran kapetanovic kompozitor
• Annette samuelsson upplands väsby
• Odd molly kappa
• Astra mölndal
• Hello fellow kids
• Gmail outlook kalender

Protara Therapeutics Inc Aktienyheter TARA - Investing.com

Find the latest Protara Therapeutics, Inc. (TARA) stock discussion in Yahoo Finance's forum.